Park Medi World
Park Medi World Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Q4 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Park Medi World plans significant bed expansion: adding 1,850 beds currently under execution, with 350 beds added at Panchkula and 200 beds at Delhi Narela. The company plans significant bed capacity expansion, aiming to increase beds from 5,460 in FY’28 to over 10,000 by FY’33, potentially doubling capacity.
From Park Medi World's Q4 FY26 earnings-call transcript · updated 24 Aug 2026.
Revenue & Sales Performance
- Park Medi World plans significant bed expansion: adding 1,850 beds currently under execution, with 350 beds added at Panchkula and 200 beds at Delhi Narela.
- Capex guidance: INR55 crores planned for the current year and approximately INR250 crores in FY28 for adding 1,000 beds.
- Long-term vision (FY28 to FY33): Plans to double bed capacity from 5,460 to over 10,000 beds.
- Expansion focus on Tier-2 and Tier-3 cities due to growing demand for affordable, high-quality healthcare, reducing patient outflow to metros.
- Continued increase in government insurance payor mix expected to stabilize around 70%.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Park Medi World said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Park Medi World is undertaking a significant bed expansion with a capex of about INR 34 lakhs per bed, aiming to increase capacity to 5,460 beds by FY’28 and potentially doubling to over 10,000 beds by FY’33.
- Current capex underway includes:
- Panchkula: 350 beds with INR 125 crores invested.
- Delhi Narela: 200 beds with total planned capex INR 80 crores (INR 55 crores spent).
- Kanpur: Additional INR 30 crores planned.
- Capex planned for FY’27 is about INR 55 crores; for FY’28, approximately INR 250 crores.
2 more points management made on capital expenditure plans
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Park Medi World said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The company currently has approximately 1,500 beds under execution.
- These new capacity additions are expected to be operational by March 2028.
- This expansion will increase total bed capacity to 5,460 by that time.
- Total planned capex for the next two years is around INR 500 crores.
- Recent investments include Panchkula Greenfield construction, and acquisitions/commissioning of Bathinda, Agra, and Narela hospitals.
2 more points management made on order book & pipeline
Park Medi World — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹460 Cr, net profit ₹77 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Park Medi World's management said in earlier quarters
Others in Healthcare Services this season
- Apollo Hospitals (Q4 FY26)
30% growth currently driven by top 5 markets; expansion planned into new markets. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q4 FY26 earnings…
- Health X Platform (Q4 FY26)
Northeast operations growing 50%+ year-on-year and Northern India 25–30%, with plans for 5–7% market share in 2-3 years (Page 10). Key concall takeaways from…
- Vimta Labs Ltd (Q4 FY26)
. Key concall takeaways from Vimta Labs Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.
- Vijaya Diagnost. (Q4 FY26)
Hyderabad to sustain double-digit growth (~20%) in near term, with additional spokes opening and market share gains. Key concall takeaways from Vijaya…
Frequently Asked Questions
What were Park Medi World Q4 FY26 results?
Park Medi World plans significant bed expansion: adding 1,850 beds currently under execution, with 350 beds added at Panchkula and 200 beds at Delhi Narela. The company plans significant bed capacity expansion, aiming to increase beds from 5,460 in FY’28 to over 10,000 by FY’33, potentially doubling capacity.
What is Park Medi World share price analysis?
Park Medi World currently shows a neutral. The stock trades at a P/E of 42.7 with a market cap of ₹11,859 Cr. Investors should review the full earnings analysis for detailed insights.
Is Park Medi World planning capital expenditure?
Park Medi World is undertaking a significant bed expansion with a capex of about INR 34 lakhs per bed, aiming to increase capacity to 5,460 beds by FY’28 and potentially doubling to over 10,000 beds by FY’33.
Keep Park Medi World on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.